 |
|
 |
Companies (Medical Device) |
|
|
Gambro Medical Device Company Intelligence Report
Publication Date January 2006
Publisher Espicom
Product Type Report
Pages 62
ISBN Number not applicable
Product Code ESP757
|
|
|
Summary
Gambro AB, headquartered in Stockholm, Sweden, is a global medical technology and healthcare company which manufactures dialysis products, operates dialysis clinics and supplies blood bank technology products.
The company had revenue of SKr 26.6 billion (US$3.6 billion) in fiscal 2004 and SKr 10.7 billion (US$1.4 billion) in the first nine months of 2005, with the latter significantly lower than in the 2004-period due to the company selling its Gambro Healthcare US operations to DaVita in October 2005. In 2004, this business generated revenue of SKr 14.1 billion. At the end of 2004, the company had almost 21,300 employees and, following the sale of its US healthcare operations, Gambro now has around 11,300 employees in 40 countries.
Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.
|
Content
- Overview
- Corporate History
- Foundation
- Recent Corporate News
- Mergers And Acquisitions
- Teraklin
- Ivex Pharmaceuticals
- Blten Dialysis Centre, Turkey
- Sanguistech
- Hospamed
- Nephrology
- O'Nil
- Vivra
- Ren Corporation-USA
- Dial Medical
- Organon Teknika's Dialysis Operations
- Farma SIAP
- Cobe
- Joint Ventures
- Termination Of Joint Ventures
- Baxter/Gambro Dialysis Manufacturing Joint Venture
- Gambro Healthcare US
- Minority Investments
- Divestitures
- Gambro Healthcare US
- MacGREGOR
- Thoratec
- Point Therapeutics
- Scandinavian Heart Center
- ABB
- Excorim Immunoadsorption Business
- Rsidence du Parc
- Cobe Cv
- Sorbent Cartridges Manufacturing Facility
- RENLStar
- Intensive Care and Anaesthesia Business
- Agreements
- DaVita
- Baxter
- Pall
- Spire Biomedical
- BTG
- Global Med Technologies
- Nipro
- Membrana
- Medisystems
- Supply Agreements
- American Red Cross
- Establissement Francais du Sang
- Litigation
- US Department of Justice
- Compliance Issues
- PTH Testing
- Former Shareholders of REN Corporation
- Fresenius
- Corporate Structure
- Gambro Renal Products
- Hospal
- Gambro Healthcare
- Gambro BCT
- Navigant Biotechnologies
- Strategic Focus
- Gambro Renal Products
- Gambro BCT
- Gambro Healthcare
- Products
- Renal Products
- Haemodialysis Products
- Haemodialysis Dialysers/Filters
- Polyflux Synthetic Dialysers
- AN69 Membrane
- An69 St
- Crystal ST Series
- Nephral ST Series
- Arylane Series
- Modified Cellulose Dialysers
- Diacepal
- Dialysis Machines
- Phoenix
- Ak 95 S
- Liver Support/Therapy Products
- Mars
- Water Treatment Products
- Central Water Purification Systems
- Concentrates
- Acid
- Bicarbonate: BiCart and BiCart Select
- Vascular Access Products and Dressings
- Plume S Fistula Needles
- Plume SP
- Gambro Plume Safety AVF Needle
- TipStop
- ClinicalKit
- Cartridge Blood Set
- QuickSet Medical Lines
- Clinical Information Systems
- Exalis
- CentryNet Software
- Dialmaster
- MedGSS Renal Management System
- Catheters
- GamCath Catheters
- GamCath Dolphin Catheters
- Haemodialysis Monitors
- Innova
- Integra
- Integra Physio
- Integra HDF
- Monitoring, Biofeedback Products and Accessories
- Bioguide
- Diaclear
- Diacontrol
- Diaguide
- Diascan
- Hemoscan
- Hemocontrol
- Quantiscan
- Techmaster
- Clinical Hardware
- Patient Card
- Other Hardware
- Bloodlines
- Bioline
- Hemoline
- Renal Intensive Care Products
- Continuous Renal Replacement Therapy Products
- Prisma, Prismaflex and Phoenix - FDA Warning Letter and Safety Alerts
- Prisma System
- Prismaflex
- Prismaflex HF1000 Set / HF1400 Set
- Prismaflex M60 Set / M100 Set
- Prisma HF 1000
- Prisma M60 and M100
- Prisma M60 and M100 Pre-Pump Infusion Sets
- Prisma TPE 2000 Set
- Prisma M10 Pre Set
- Miniflow 10
- Prismars
- Prismatherm II
- PrismaSate Dialysate
- Prismaflo
- Disposable Sets
- Multiflow Kits
- Blood Access Products
- Hemoaccess
- Adsorba C
- Peritoneal Dialysis Products
- PD Cyclers
- Serena
- Serena: BREAKpoint PD System
- Solution Bags
- Gambrosol trio
- BLOOD COMPONENT TECHNOLOGY (BCT)
- Elutra Cell Separation System
- Automated Blood Collection
- Trima
- Trima Accel Automated Blood Collection System
- Trima Seal Safe
- Vista Information Management System
- OrbiSac System
- Spectra Apheresis System
- Seal Safe Kit
- SpectraTHERM
- Single Needle Return Flow Controller
- COBE 2991 Cell Processor
- Accessories
- White Blood Cell Tubing Set
- AutoPBSC Tubing Set
- Bone Marrow Tubing Set
- Therapeutic Plasma Exchange Tubing Set
- Red Blood Cell Exchange Tubing Set
- Extended Life Platelet (ELP) Tubing Set
- Extended Life Platelet Tubing Set with LRS Chamber
- Accessory Storage Platelet Bag
- International Activities
- Europe
- Czech Republic
- France
- Germany
- Italy
- Sweden
- Turkey
- United Kingdom
- Asia
- North America
- Latin America
- Research And Development
- Research Establishments
- Research Projects
- Mirasol Pathogen Reduction Technology
- US Department of Defense
- US Centers for Disease Control
- Sangart
- Walter Reed Army Institute of Research
- Atreus
- Gambro Hospal UK Projects
- Research Agreements
- Financial Review
- Financial Indicators
- Financial Highlights
- Commentary
- First Nine Months of Fiscal 2005
- Outlook
- FISCAL 2004
- Operating Divisions
- Revenue by Operating Division, 2003-2004 (SKr million)
- External Revenue by Operating Division: 2003-2004 (SKr million)
- EBIT by Division: 2003-2004 (SKr million)
- Segment Assets by Division, 2003-2004 (SKr million)
- Gambro Healthcare
- Gambro Renal Products
- Global Dialysis Products Market Share, 2004*
- Gambro BCT
- Global Review
- Gambro Healthcare
- Gambro Renal Products
- Gambro BCT
- Sales to External Customers by Geographic Area, 2003-2004 (SKr million)
- Assets by Geographic Region, 2003-2004 (SKr million)
- Gambro Healthcare: Revenue by Geographic Area, 2003-2004 (SKr million)
- Gambro Renal Products: Sales to External Customers by Region, 2003-2004 (SKr million)
- Gambro BCT: Revenue by Geographic Area, 2003-2004 (SKr million)
- Index Of Tables
- Financial Indicators
- Revenue by Operating Division, 2003-2004 (SKr million)
- External Revenue by Operating Division: 2003-2004 (SKr million)
- EBIT by Division: 2003-2004 (SKr million)
- Segment Assets by Division, 2003-2004 (SKr million)
- Global Dialysis Products Market Share, 2004*
- Sales to External Customers by Geographic Area, 2003-2004 (SKr million)
- Assets by Geographic Region, 2003-2004 (SKr million)
- Gambro Healthcare: Revenue by Geographic Area, 2003-2004 (SKr million)
- Gambro Renal Products: Sales to External Customers by Region, 2003-2004 (SKr million)
- Gambro BCT: Revenue by Geographic Area, 2003-2004 (SKr million)
- Index Of Charts
- Fig.1: Percentage of Revenue by Business Area, 2004*
- Fig.2: Global Market Shares for Dialysis Products, 2004*
- Fig.3: Apheresis Blood Bank Technology - Automated Collection - Market Share, 2004*
- Fig.4: Therapeutic Apheresis and Cell Therapies Market Share, 2004*
- Fig.5: Sales to External Customers by Geographic Market, 2004
- Fig.6: Gambro Healthcare; Revenue by Region, 2004
- Fig.7: Gambro Renal Products; Sales to External Customers by Region, 2004
- Fig.8: Gambro BCT; Percentage of Revenue by Region, 2004
|
|
|
